Will DocuSign report dollar-based net retention (DNR) at or above 103% by Q2 FY2027?

Base rate extrapolation: DNR improved 1pp/quarter for five consecutive quarters (Q3 FY2025 through Q3 FY2026), then stalled at 102% for two quarters (Q3 and Q4 FY2026). The stall breaks the linear trend. If improvement resumes at even a slower pace (0.5pp/quarter), 103% is reachable by Q2 FY2027. The two-quarter window doubles the probability of catching any given improvement. Historical trend weight favors YES, but the two-quarter stall at 102% indicates a potential structural plateau. Weighting the 5-quarter trend against the 2-quarter stall: ~55%.

Historical trend decomposition: the 98%→102% move was driven by stabilization of churn post-pandemic and early IAM upsell. The stall at 102% may reflect exhaustion of the first wave of easy wins. A second wave (IAM renewals at scale) could restart improvement, but IAM is only 10.8% of ARR — the 89.2% non-IAM base is structurally flat per CFO. For company-level DNR to move from 102% to 103%, the IAM cohort's above-average DNR must be strong enough to pull the blended average up despite the large flat base. At 10.8% mix, IAM DNR would need to be ~112%+ to pull the blended metric up 1pp. Plausible but not certain. Two-quarter window helps: ~52%.

Trend continuation analysis: companies that show sustained multi-quarter improvement in net retention rarely permanently stall at a single level. The 102% plateau may reflect seasonal reporting noise — Q3 and Q4 FY2026 both at 102% could be coincidental, especially since Q4 is the heaviest renewal quarter and renewal outcomes in Q4 feed into Q1/Q2 reported metrics. The five consecutive quarters of improvement represent a genuine structural shift (IAM, consumption pricing, enterprise expansion). Management guided 'another year of modest improvement' — this language is forward-looking and specific enough to suggest internal data supports continued improvement. Weighting the multi-quarter structural trend more heavily than the 2-quarter stall: ~58%.

Management guidance analysis: CFO said 'another year of modest improvement in DNR' for FY2027. 'Modest improvement' from 102% implies 103% is the most likely landing zone for the full year. But management also noted renewals are 'seasonally weighted more heavily to the second half of the year, in particular, Q4.' This seasonal pattern suggests Q1/Q2 may not capture the improvement — it could be back-loaded to Q3/Q4. If management expects 103% by year-end but the path is H2-weighted, Q1/Q2 may still show 102%. The guidance supports improvement happening but timing may miss this market's window: ~48%.

Guidance decomposition: management's use of 'another year' implies FY2027 will deliver similar pace to FY2026 (which improved from 99% to 102% over 4 quarters). If FY2027 delivers a similar 3pp improvement from 102%, that reaches 105% by Q4 FY2027. But FY2026's improvement was front-loaded (Q1-Q3 each +1pp, Q4 stalled). If FY2027 improvement is also front-loaded, Q1 could show 103%. However, CFO explicitly noted H2 renewal weighting. The tension between 'another year of improvement' (bullish for full year) and 'H2 weighted renewals' (bearish for Q1/Q2 timing) creates a near-coin-flip for this market's window: ~50%.

Guidance skepticism analysis: management's Q4 earnings call language on IAM retention shifted from Q3's confident 'several percentage points higher than corporate average' to Q4's cautious 'better than company average' and 'very early days.' This tonal downshift suggests IAM retention data may have been less impressive in Q4 than Q3. If the IAM retention signal is weakening rather than strengthening, the mechanism for pushing DNR from 102% to 103% is impaired. Combined with seasonal H2 weighting and the two-quarter stall, the case for Q1/Q2 reaching 103% is slightly below even odds: ~45%.

Cross-signal analysis: multiple signals converge on continued improvement. $300K+ customers grew 7% YoY (1,165→1,205), indicating healthy large-account expansion that feeds DNR. Envelope consumption at 'near multiyear highs' signals usage-based expansion. New consumption-based pricing launching Q1 FY2027 could incrementally lift DNR as usage-based billing is inherently expansion-oriented. IAM ARR growing from ~$70M to $350M+ shows the expansion engine is real. The question is magnitude and timing. Cross-signal consensus: improvement continues, 103% reachable within 2 quarters but not certain: ~53%.

Cross-signal caution: while expansion signals are positive, the stall at 102% occurred despite these same positive signals being present in Q3 and Q4 FY2026. Envelope consumption was already high, IAM was already growing, and $300K+ customers were already expanding — yet DNR couldn't breach 102%. This suggests the positive expansion signals are already priced into the 102% level and incremental improvement requires genuinely new catalysts (IAM at scale, consumption pricing impact). New catalysts take time to show up in reported DNR. The predecessor market (docu-q4-fy26-dnr-above-103) resolved NO despite similar bullish signals: ~47%.

Cross-signal integration with calibration: the predecessor market resolved NO at 102%, but this market has a critical structural advantage — a two-quarter window vs single quarter, and Q1/Q2 FY2027 benefits from Q4 FY2026 heavy renewal outcomes flowing through. The new IAM SKUs (HR, Procurement) launching in FY2027 create fresh expansion surfaces. IAM is approaching ~18% of total ARR by FY2027 target, up from 10.8% — at this mix, IAM's above-average retention has more mathematical weight on the blended metric. The reporting metric risk is low (resolution criteria accounts for metric changes). Net assessment slightly favoring YES given the two-quarter window and growing IAM mix: ~56%.